dc.contributor.author | Calderón-Pérez, Lorena | |
dc.contributor.author | Suárez-García, Susana | |
dc.contributor.author | Pedret, Anna | |
dc.contributor.author | Suárez, Manuel | |
dc.contributor.author | Llauradó, Elisabet | |
dc.contributor.author | Rubió Piqué, Laura | |
dc.contributor.author | Bas, Josep M. del | |
dc.contributor.author | Caimari, Antoni | |
dc.contributor.author | Puiggrós, Francesc | |
dc.contributor.author | Arola, Lluís | |
dc.contributor.author | Solà, Rosa | |
dc.contributor.author | Valls, Rosa M. | |
dc.date.accessioned | 2022-04-27T10:19:50Z | |
dc.date.available | 2022-04-27T10:19:50Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1532-1983 | |
dc.identifier.uri | http://hdl.handle.net/10459.1/83162 | |
dc.description.abstract | Background & aims: Whether bioactive lysophospholipids (lyso-PLs) and trimethylamine-N-oxide
(TMAO) serve as non-invasive biomarkers in early human hypercholesterolemia (HC) is unknown. This
study aimed to assess whether serum lyso-PLs and plasma TMAO may be suitable susceptibility/risk
biomarkers of HC in humans. Secondarily, we aimed to evaluate the relationships between targeted
metabolites, diet composition and circulating liver transaminases, and verify these results in hamsters.
Methods: A targeted metabolomics and lipidomics approach determined plasma TMAO and serum
lysophosphatidylcholines (lyso-PCs) and lysophosphatidylethanolamines (lyso-PEs) in low (L-LDL-c) and
moderate to high (MH-LDL-c) LDL-cholesterol subjects. Additionally, the relationships between targeted
metabolites, liver transaminases and diet, particularly fatty acid intake, were tested. In parallel, plasma
and liver lyso-PL profiles were studied in 16 hamsters fed a moderate high-fat (HFD) or low-fat (LFD) diet
for 30 days.
Results: Predictive models identified lyso-PC15:0 and lyso-PE18:2 as the most discriminant lyso-PLs
among groups. In MH-LDL-c (n ¼ 48), LDL-cholesterol and saturated FAs were positively associated
with lyso-PC15:0, whereas in L-LDL-c (n ¼ 70), LDL-cholesterol and polyunsaturated fatty acids (PUFAs)
were negatively and positively related to lyso-PE18:2, respectively. Interestingly, in MH-LDL-c, the lower
lyso-PE 18:2 concentrations were indicative of higher LDL-cholesterol levels. Intrahepatic accumulation
of lyso-PLs-containing essential n-6 PUFAs, including lyso-PE18:2, were higher in HFD-fed hamsters than
LFD-fed hamsters. | ca_ES |
dc.description.sponsorship | The research leading to these results was supported by the Eu-ropean Commission through its Seventh Framework Programme "BIOmarkers of Robustness of Metabolic Homeostasis for Nutrigenomics-derived Health CLAIMS Made on Food" Project (FP7-KBBE-20 09-3 BIOCLAIMS) under grant agreement number 244995. Additionally, it was financially supported by the Centre for the Development of Industrial Technology (CDTI) of the Spanish Ministry of Science and Innovation under grant agreement: TEC-NOMIFOOD project (CER-20191010) | |
dc.language.iso | eng | ca_ES |
dc.publisher | Elsevier | ca_ES |
dc.relation.isformatof | Reproducció del document publicat a https://doi.org/10.1016/j.clnu.2021.11.033 | ca_ES |
dc.relation.ispartof | Clinical nutrition, 2022, vol. 41, núm. 2, p.489-499 | ca_ES |
dc.rights | cc-by, (c) Calderón et al., 2022 | ca_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Lysophospholipids | ca_ES |
dc.subject | Lysophosphatidylcholines | ca_ES |
dc.subject | Lysophosphatidylethanolamines | ca_ES |
dc.subject | Trimethylamine-N-Oxide | ca_ES |
dc.subject | Hypercholesterolemia | ca_ES |
dc.subject | Polyunsaturated fatty acids | ca_ES |
dc.title | Serum lysophospholipidome of dietary origin as a suitable susceptibility/risk biomarker of human hypercholesterolemia: a cross-sectional study | ca_ES |
dc.type | info:eu-repo/semantics/article | ca_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | ca_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_ES |
dc.identifier.doi | https://doi.org/10.1016/j.clnu.2021.11.033 | |